Evidence map›Paper›PMID 36328423›Full record

ArticleJournal of medical genetics2023

In-depth characterisation of a cohort of individuals with missense and loss-of-function variants disrupting

Lottie D Morison, Elisabeth Meffert, Miriam Stampfer, Irene Steiner-Wilke, Brigitte Vollmer, Katrin Schulze, Tracy Briggs, Ruth Braden, Adam Vogel, Daisy Thompson-Lake and 13 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of medical genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Gene Expression-Based Lesion-Symptom Mapping:The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Monogenic disorders associated with motor speech phenotypes in children and adolescents undergoing clinical exome sequencing.Genetics in medicine : official journal of the American College of Medical Genetics · 2025
    Article
  9. Article
  10. Speech and language classification in the human phenotype ontology.European journal of human genetics : EJHG · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Evo-devo applied to sleep research: an approach whose time has come.Sleep advances : a journal of the Sleep Research Society · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 17 institutions in 5 countries.

Lottie D MorisonSpeech and Language, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.ORCID 0000-0003-2822-6522
Elisabeth MeffertSRH University of Applied Health Sciences, Gera, Germany.
Miriam StampferMedical Genetics Center, Munich, Germany.
Irene Steiner-WilkeCentre for Cleft Palate & Craniofacial Malformations, Tuebingen University Hospital, Tubingen, Germany.
Brigitte VollmerClinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
Katrin SchulzeDepartment of Psychology, Heidelberg University, Heidelberg, Germany.
Tracy BriggsDivision of Evolution and Genomic Sciences, Faculty of Biology, Medicine and Health, School of Biological Sciences, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
Ruth BradenSpeech and Language, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
Adam VogelCentre for Neuroscience of Speech, University of Melbourne, Melbourne, Victoria, Australia.ORCID 0000-0002-3505-2631
Daisy Thompson-LakeGreat Ormond Street Institute of Child Health, University College London, London, UK.
Chirag PatelGenetic Health Queensland, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
Edward BlairOxford Centre for Genomic Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Himanshu GoelHunter Genetics, Waratah, New South Wales, Australia.
Samantha TurnerSpeech and Language, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
Ute MoogInstitute of Human Genetics, Heidelberg University, Heidelberg, Germany.
Angelika RiessInstitute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
Frederique LiegeoisGreat Ormond Street Institute of Child Health, University College London, London, UK.
David A KoolenDepartment of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center (Radboudumc), Nijmegen, The Netherlands.
David J AmorSpeech and Language, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
Tjitske KleefstraDepartment of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center (Radboudumc), Nijmegen, The Netherlands.
Simon E FisherLanguage and Genetics, Max Planck Institute for Psycholinguistics, Nijmegen, The Netherlands.ORCID 0000-0002-3132-1996
Christiane ZweierInstitute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Angela T MorganSpeech and Language, Murdoch Children's Research Institute, Melbourne, Victoria, Australia angela.morgan@mcri.edu.au.ORCID 0000-0003-1147-7405
Radboud University Nijmegen · NLGreat Ormond Street Hospital · GBHeidelberg University · DEMurdoch Children's Research Institute · AURoyal Children's Hospital · AUHunter Genetics · AULa Trobe University · AUManchester Academic Health Science Centre · GBMedical Genetics Center · DEOxford University Hospitals NHS Trust · GBRoyal Brisbane and Women's Hospital · AUSRH Hochschule für Gesundheit Gera · DEThe University of Melbourne · AUUniversity Children's Hospital Tübingen · DEUniversity Hospital Southampton NHS Foundation Trust · GBUniversity of Bern · CHUniversity of Tübingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHeterozygous disruptions of

methodsHere we phenotyped 28 individuals from 17 families with pathogenic

resultsSpeech disorders were prevalent (23/25, 92%) and CAS was most common (22/25, 88%), with similar speech presentations across English and German. Speech was still impaired in adulthood, and some speech sounds (eg, 'th', 'r', 'ch', 'j') were never acquired. Language impairments (21/25, 84%) ranged from mild to severe. Comorbidities included feeding difficulties in infancy (10/26, 38%), fine (13/26, 50%) and gross (13/26, 50%) motor impairment, anxiety (5/27, 19%), depression (6/27, 22%) and sleep disturbance (10/24, 42%). Physical features were common (22/27, 81%) but with no consistent pattern. Cognition ranged from average to mildly impaired and was incongruent with language ability; for example, seven participants with severe language disorder had average non-verbal cognition.

conclusionsAlthough we identify an increased prevalence of conditions like anxiety, depression and sleep disturbance, we confirm that the consequences of

Indexed as

ApraxiasLanguage DisordersChildForkhead Transcription FactorsHumansMaleMutation, MissenseSpeechSpeech DisordersForkhead Transcription FactorsFOXP2 protein, humangeneticsgenotypepaediatricsphenotype

Identifiers

PMID36328423
PMCPMC10314088
OpenAlexW4308185912

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.